U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C31H30FN5O4
Molecular Weight 555.5994
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DANUGLIPRON

SMILES

OC(=O)C1=CC2=C(C=C1)N=C(CN3CCC(CC3)C4=NC(OCC5=CC=C(C=C5F)C#N)=CC=C4)N2C[C@@H]6CCO6

InChI

InChIKey=HYBAKUMPISVZQP-DEOSSOPVSA-N
InChI=1S/C31H30FN5O4/c32-25-14-20(16-33)4-5-23(25)19-41-30-3-1-2-26(35-30)21-8-11-36(12-9-21)18-29-34-27-7-6-22(31(38)39)15-28(27)37(29)17-24-10-13-40-24/h1-7,14-15,21,24H,8-13,17-19H2,(H,38,39)/t24-/m0/s1

HIDE SMILES / InChI
Molecular Formula C31H30FN5O4
Molecular Weight 555.5994
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Unknown
149124
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
136 ng/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/36433713/
40 mg 2 times / day steady-state, oral
dose: 40 mg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
DANUGLIPRON plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
245.3 ng/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/36433713/
80 mg 2 times / day steady-state, oral
dose: 80 mg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
DANUGLIPRON plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
415.8 ng/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/36433713/
120 mg 2 times / day steady-state, oral
dose: 120 mg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
DANUGLIPRON plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
2424 ng × h/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/36433713/
40 mg 2 times / day steady-state, oral
dose: 40 mg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
DANUGLIPRON plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
4691 ng × h/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/36433713/
80 mg 2 times / day steady-state, oral
dose: 80 mg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
DANUGLIPRON plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
6953 ng × h/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/36433713/
120 mg 2 times / day steady-state, oral
dose: 120 mg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
DANUGLIPRON plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
6.373 h
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/36433713/
40 mg 2 times / day steady-state, oral
dose: 40 mg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
DANUGLIPRON plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
5.543 h
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/36433713/
80 mg 2 times / day steady-state, oral
dose: 80 mg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
DANUGLIPRON plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
5.3 h
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/36433713/
120 mg 2 times / day steady-state, oral
dose: 120 mg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
DANUGLIPRON plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
Substance Class Chemical
Created
by admin
on Tue Apr 01 22:15:13 GMT 2025
Edited
by admin
on Tue Apr 01 22:15:13 GMT 2025
Record UNII
DN9IUI24GP
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PF-06882961
Preferred Name English
DANUGLIPRON
USAN  
Official Name English
Danuglipron [WHO-DD]
Common Name English
1H-BENZIMIDAZOLE-6-CARBOXYLIC ACID, 2-((4-(6-((4-CYANO-2-FLUOROPHENYL)METHOXY)-2-PYRIDINYL)-1-PIPERIDINYL)METHYL)-1-((2S)-2-OXETANYLMETHYL)-
Systematic Name English
DANUGLIPRON [USAN]
Common Name English
2-((4-(6-((4-CYANO-2-FLUOROBENZYL)OXY)PYRIDIN-2-YL)PIPERIDIN-1-YL)METHYL)-1-((2S)-OXETAN-2- YLMETHYL)-1H-BENZIMIDAZOLE-6-CARBOXYLIC ACID
Common Name English
danuglipron [INN]
Common Name English
Code System Code Type Description
FDA UNII
DN9IUI24GP
Created by admin on Tue Apr 01 22:15:13 GMT 2025 , Edited by admin on Tue Apr 01 22:15:13 GMT 2025
PRIMARY
SMS_ID
300000028080
Created by admin on Tue Apr 01 22:15:13 GMT 2025 , Edited by admin on Tue Apr 01 22:15:13 GMT 2025
PRIMARY
INN
11630
Created by admin on Tue Apr 01 22:15:13 GMT 2025 , Edited by admin on Tue Apr 01 22:15:13 GMT 2025
PRIMARY
USAN
HI-76
Created by admin on Tue Apr 01 22:15:13 GMT 2025 , Edited by admin on Tue Apr 01 22:15:13 GMT 2025
PRIMARY
CAS
2230198-02-2
Created by admin on Tue Apr 01 22:15:13 GMT 2025 , Edited by admin on Tue Apr 01 22:15:13 GMT 2025
PRIMARY
NCI_THESAURUS
C177080
Created by admin on Tue Apr 01 22:15:13 GMT 2025 , Edited by admin on Tue Apr 01 22:15:13 GMT 2025
PRIMARY
PUBCHEM
134611040
Created by admin on Tue Apr 01 22:15:13 GMT 2025 , Edited by admin on Tue Apr 01 22:15:13 GMT 2025
PRIMARY
EPA CompTox
DTXSID601101457
Created by admin on Tue Apr 01 22:15:13 GMT 2025 , Edited by admin on Tue Apr 01 22:15:13 GMT 2025
PRIMARY
Related Record Type Details
Structure of DANUGLIPRON TROMETHAMINE
SALT/SOLVATE -> PARENT
GLUCAGON-LIKE PEPTIDE 1 RECEPTOR
TARGET -> AGONIST
Related Record Type Details
Structure of DANUGLIPRON
ACTIVE MOIETY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966